162 related articles for article (PubMed ID: 30100995)
1. RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance.
Cajigas-Du Ross CK; Martinez SR; Woods-Burnham L; Durán AM; Roy S; Basu A; Ramirez JA; Ortiz-Hernández GL; Ríos-Colón L; Chirshev E; Sanchez-Hernandez ES; Soto U; Greco C; Boucheix C; Chen X; Unternaehrer J; Wang C; Casiano CA
Oncotarget; 2018 Jul; 9(54):30363-30384. PubMed ID: 30100995
[TBL] [Abstract][Full Text] [Related]
2. Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes.
Ríos-Colón L; Cajigas-Du Ross CK; Basu A; Elix C; Alicea-Polanco I; Sanchez TW; Radhakrishnan V; Chen CS; Casiano CA
Oncotarget; 2017 Apr; 8(15):24915-24931. PubMed ID: 28212536
[TBL] [Abstract][Full Text] [Related]
3. Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate Cancers.
Mitra Ghosh T; Mazumder S; Davis J; Yadav J; Akinpelu A; Alnaim A; Kumar H; Waliagha R; Church Bird AE; Rais-Bahrami S; Bird RC; Mistriotis P; Mishra A; Yates CC; Mitra AK; Arnold RD
Cancer Res Commun; 2023 Jul; 3(7):1286-1311. PubMed ID: 37476073
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells.
Sanchez-Hernandez ES; Ochoa PT; Suzuki T; Ortiz-Hernandez GL; Unternaehrer JJ; Alkashgari HR; Diaz Osterman CJ; Martinez SR; Chen Z; Kremsky I; Wang C; Casiano CA
Cells; 2023 Aug; 12(16):. PubMed ID: 37626856
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid Receptor and β-Catenin Interact in Prostate Cancer Cells and Their Co-Inhibition Attenuates Tumorsphere Formation, Stemness, and Docetaxel Resistance.
Martinez SR; Elix CC; Ochoa PT; Sanchez-Hernandez ES; Alkashgari HR; Ortiz-Hernandez GL; Zhang L; Casiano CA
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108293
[TBL] [Abstract][Full Text] [Related]
6. Itraconazole Reverts ABCB1-Mediated Docetaxel Resistance in Prostate Cancer.
Lima TS; Souza LO; Iglesias-Gato D; Elversang J; Jørgensen FS; Kallunki T; Røder MA; Brasso K; Moreira JMA
Front Pharmacol; 2022; 13():869461. PubMed ID: 35721223
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer.
Gravina GL; Mancini A; Colapietro A; Marampon F; Sferra R; Pompili S; Biordi LA; Iorio R; Flati V; Argueta C; Landesman Y; Kauffman M; Shacham S; Festuccia C
Oncotarget; 2017 Dec; 8(67):111225-111245. PubMed ID: 29340049
[TBL] [Abstract][Full Text] [Related]
8. Enhanced anti-tumor efficacy and mechanisms associated with docetaxel-piperine combination-
Li C; Wang Z; Wang Q; Ka Yan Ho RL; Huang Y; Chow MSS; Kei Lam CW; Zuo Z
Oncotarget; 2018 Jan; 9(3):3338-3352. PubMed ID: 29423050
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
10. Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells.
Patterson SG; Wei S; Chen X; Sallman DA; Gilvary DL; Zhong B; Pow-Sang J; Yeatman T; Djeu JY
Oncogene; 2006 Oct; 25(45):6113-22. PubMed ID: 16652143
[TBL] [Abstract][Full Text] [Related]
11. Curcumin Nanoparticles and Their Cytotoxicity in Docetaxel-Resistant Castration-Resistant Prostate Cancer Cells.
Tanaudommongkon I; Tanaudommongkon A; Prathipati P; Nguyen JT; Keller ET; Dong X
Biomedicines; 2020 Jul; 8(8):. PubMed ID: 32751450
[TBL] [Abstract][Full Text] [Related]
12. Overcoming chemoresistance in prostate cancer with Chinese medicine Tripterygium wilfordii via multiple mechanisms.
Wang Z; Ravula R; Shi L; Song Y; Yeung S; Liu M; Lau B; Hao J; Wang J; Lam CW; Chow MS; Huang Y
Oncotarget; 2016 Sep; 7(38):61246-61261. PubMed ID: 27487134
[TBL] [Abstract][Full Text] [Related]
13. Targeting MRP4 expression by anti-androgen treatment reverses MRP4-mediated docetaxel resistance in castration-resistant prostate cancer.
Li YF; Ji HH; Zhang ZL; Zhang TT; Gan W; Zhang SF
Oncol Lett; 2017 Aug; 14(2):1748-1756. PubMed ID: 28789405
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.
Pistore C; Giannoni E; Colangelo T; Rizzo F; Magnani E; Muccillo L; Giurato G; Mancini M; Rizzo S; Riccardi M; Sahnane N; Del Vescovo V; Kishore K; Mandruzzato M; Macchi F; Pelizzola M; Denti MA; Furlan D; Weisz A; Colantuoni V; Chiarugi P; Bonapace IM
Oncogene; 2017 Oct; 36(40):5551-5566. PubMed ID: 28581528
[TBL] [Abstract][Full Text] [Related]
15. Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells.
Liu H; Song X; Hou J; Zhao Z; Chang J
DNA Cell Biol; 2018 Mar; 37(3):210-219. PubMed ID: 29327946
[TBL] [Abstract][Full Text] [Related]
16. circCYP24A1 promotes Docetaxel resistance in prostate Cancer by Upregulating ALDH1A3.
Yin H; Qin H; Yang L; Chen M; Yang Y; Zhang W; Hao J; Lu Q; Shi J; Zhuang J; Qiu X; Guo H
Biomark Res; 2022 Jul; 10(1):48. PubMed ID: 35831872
[TBL] [Abstract][Full Text] [Related]
17. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
[TBL] [Abstract][Full Text] [Related]
18. Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells.
Cánovas V; Puñal Y; Maggio V; Redondo E; Marín M; Mellado B; Olivan M; Lleonart M; Planas J; Morote J; Paciucci R
Oncotarget; 2017 Aug; 8(35):59165-59180. PubMed ID: 28938627
[TBL] [Abstract][Full Text] [Related]
19. KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer.
Sekino Y; Oue N; Koike Y; Shigematsu Y; Sakamoto N; Sentani K; Teishima J; Shiota M; Matsubara A; Yasui W
J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30744126
[TBL] [Abstract][Full Text] [Related]
20. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]